Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mina Ishimori
Observed name:
Mina ISHIMORI
Institution:
Bayer (Japan)
Observed institutions:
Bayer (Japan),
The University of Tokyo
OpenAlex ID:
A5113524345
The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in Rodents
2003
·
Noriyuki Yamamoto
, Keisuke Takeshita
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
206
A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity
2005
·
Karl Ziegelbauer
, Florian Gantner
, et al.
·
British Journal of Pharmacology
·
172
PAR-2 Deficient CD4+ T Cells Exhibit Downregulation of IL-4 and Upregulation of IFN-γ after Antigen Challenge in Mice
2006
·
Michitaka Shichijo
, Shinichi Kondo
, et al.
·
Allergology International
·
17
PDF
Antigen Presentation by Peyer's Patch Cells Can Induce both Th1- and Th2-type Responses Depending on Antigen Dosage, but a Different Cytokine Response Pattern from That of Spleen Cells
2002
·
Tadashi YOSHIDA
, Satoshi HACHIMURA
, et al.
·
Bioscience Biotechnology and Biochemistry
·
16
Interleukin 12 and CD86 Regulate Th1 and Th2 Development Induced by a Range of Antigen Doses Presented by Peyer's Patch and Spleen Cells
2003
·
Tadashi Yoshida
, Satoshi Hachimura
, et al.
·
Cytotechnology
·
9
PDF
Show more works
View as search
Works count:
5
Citation count:
409
H-index:
5
I10-index:
4
Year
Topic
Type